A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal

Clinical trial NCT07333742 · COMPLETED

Trial details

NCT number: NCT07333742
Sponsor: LG Chem
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Fed Conditions Healthy Volunteer

Start date: 2025-09-29
Primary completion: 2025-11-27
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.